CRTX.L
CRISM Therapeutics Corporation focuses on drug delivery technology to improve the clinical performance of cancer drugs as treatments for solid tumors. Its lead product, ChemoSeed that can be implanted directly into a tumor or the resection margin following the removal of a tumor, ensuring effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. Its ChemoSeed used for treatment of gliomas, a brain tumor. The company was founded in 2016 and is based in Road Town, the British Virgin Islands.
Industry
Biotechnology
IPO Date
2003-10-17
Stock Exchange
LSE
Ticker
CRTX.L
According to CRISM Therapeutics Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -2.75. This represents a change of 22.31% compared to the average of -2.25 of the last 4 quarters.
The mean historical PE Ratio of CRISM Therapeutics Corporation over the last ten years is -693.56. The current -2.75 PE Ratio has changed -60.35% with respect to the historical average. Over the past ten years (40 quarters), CRTX.L's PE Ratio was at its highest in in the June 2021 quarter at 32.89. The PE Ratio was at its lowest in in the December 2017 quarter at -2453.09.
Average
-693.56
Median
-10.78
Minimum
-4906.18
Maximum
-0.17
Discovering the peaks and valleys of CRISM Therapeutics Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 733.40%
Maximum Annual PE Ratio = -0.17
Minimum Annual Increase = -99.78%
Minimum Annual PE Ratio = -4906.18
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.38 | 733.40% |
| 2023 | -0.17 | -97.59% |
| 2022 | -6.88 | -66.69% |
| 2021 | -20.64 | 83.51% |
| 2020 | -11.25 | 6.11% |
| 2019 | -10.60 | -1.65% |
| 2018 | -10.78 | -99.78% |
| 2017 | -4906.18 | 285.05% |
The current PE Ratio of CRISM Therapeutics Corporation (CRTX.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.81
5-year avg
-8.06
10-year avg
-693.56
CRISM Therapeutics Corporation’s PE Ratio is greater than Tissue Regenix Group plc (-9.58), less than Theracryf Plc (-0.69), less than MyHealthChecked PLC (-2.34), less than Proteome Sciences plc (-2.30), greater than N4 Pharma Plc (-3.01), less than Oxford BioDynamics Plc (-0.18), greater than Cizzle Biotechnology Holdings Plc (-2.93), less than Roquefort Therapeutics plc (-1.80), less than Chill Brands Group PLC (-1.33), less than Feedback plc (-0.47),
| Company | PE Ratio | Market cap |
|---|---|---|
| -9.58 | N/A | |
| -0.69 | N/A | |
| -2.34 | N/A | |
| -2.30 | N/A | |
| -3.01 | N/A | |
| -0.18 | N/A | |
| -2.93 | N/A | |
| -1.80 | N/A | |
| -1.33 | N/A | |
| -0.47 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CRISM Therapeutics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CRISM Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CRISM Therapeutics Corporation's PE Ratio?
How is the PE Ratio calculated for CRISM Therapeutics Corporation (CRTX.L)?
What is the highest PE Ratio for CRISM Therapeutics Corporation (CRTX.L)?
What is the 3-year average PE Ratio for CRISM Therapeutics Corporation (CRTX.L)?
What is the 5-year average PE Ratio for CRISM Therapeutics Corporation (CRTX.L)?
How does the current PE Ratio for CRISM Therapeutics Corporation (CRTX.L) compare to its historical average?